Loading…
Loading…
The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing primarily in equities of U.S. companies that the fund’s adviser, Grantham, Mayo, Van Otterloo & Co. LLC (“GMO” or the “Adviser”), believes to be of high quality. Equity securities primarily include common and preferred stocks and, to a lesser extent, other stock-related securities, such as convertible securities, depositary receipts, equity real estate investment trusts, income trusts, and securities of other investment companies that investment primarily in equity securities.
Is QLTY's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
GMO U.S. Quality ETF employs an active, quality-centered strategy that brings together fundamental and quantitative methods. I maintain the Hold rating on QLTY owing to its recent underperformance vs. IVV, unappealing risk metrics, and the factor mix light in GARP stocks. Quality characteristics of the QLTY portfolio are impressive, yet they alone cannot drive outperformance.
QLTY: Excellent Factor Mix, Robust Returns, A Few Issues Not To Overlook
The GMO U.S. Quality ETF (NASDAQ:QLTY) has attracted $3 billion since launching in November 2023 by focusing on companies with exceptional returns on capital.
Each month brings new ETFs to the ever-expanding ETF ecosystem. And October had its fair share of intriguing launches.
On the latest ETF 360, VettaFi's Cinthia Murphy interviewed GMO Asset Allocation's Asset Allocation Strategist Catherine LeGraw. The two discussed quality, the speculative market, and value dislocation.